Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Immunother. 2013 Sep;36(7):382–389. doi: 10.1097/CJI.0b013e31829fb7a2

Figure 3. Increased levels of peak and post-induction dose 2 mesothelin-specific T cells are associated with longer survival.

Figure 3

Frequencies of mesothelin-specific T cells measured by IFNγ ELISPOT in PBL isolated A) prior to treatment, B) following the initial treatment, C) following the second treatment and D) at the time of peak induction are plotted against overall survival. Linear regressions were performed and respective p values are shown for each timepoint.